USD $1.00-10.00 / Kilogram
product namepolyinosinic acid
structural formula (c10h13n4o8p)n cas30918-54-8
standard sda national drug standard
product namepolyinosinic acid 30918-54-8
standard ws1-xg-048-2000. main assay is not less than 92.0%, hyperchromic effect with polycytidine monophosphate>65%,
the output of injection/kg> 0.47 million pieces(2mg2ml). introduction it can be used in the therapy of herpes simplex keratitis, herpes zoster, herpeticgingivostomatitis, it also can offer good effects to hepatitis b, epidemic hemorrhagic fever, virus flu and flat wart. moreover, it can cure nasopharyngeal cancer and gynecologic cancers. packing250g/bottle 500g/bottle polyinosinic acid (poly i) 30918-54-8 cas no. 30918-54-8 itemsrequirementsresultsdescription white powder or off- white powder ,easily soluble in water ,practically insoluble in ethanol,ether .conformity absorption ratioa250 / a260 = 1.59~1.65a280 / a260 = 0.27~0.31λmax=248nma250 / a260 = 1.61a280 / a260 = 0.30λmax=248.5nmph6.0~8.08.0transmittance of solutionnot less than 98.0% 99.4%clarity of solutionconformityconformityloss on dryingnot more than8.0%6.8%sendiment coefficientnot less than 4sconformitycontents (on drysis)not less than90.0% 91.6%polycytidylic acid cas no30918-54-8 purity 98% 99% free sample of same for test iso,gmp factory polyinosinic acid (poly i) cas no. 30918-54-8 itemsrequirementsresultsdescription white powder or off- white powder ,easily soluble in water ,practically insoluble in ethanol,ether .conformity absorption ratioa250 / a260 = 1.59~1.65a280 / a260 = 0.27~0.31λmax=248nma250 / a260 = 1.61a280 / a260 = 0.30λmax=248.5nmph6.0~8.08.0transmittance of solutionnot less than 98.0%99.4%clarity of solutionconformityconformityloss on dryingnot more than8.0%6.8%sendiment coefficientnot less than 4sconformitycontpolyproduct namepolyinosinic acidstructural formula (c10h13n4o8p)ncas30918-54-8standard sda national drug standard product namepolyinosinic acid structural formula (c10h13n4o8p)n cas30918-54-8 standard sda national drug standard ws1-xg-048-2000. main assay is not less than 92.0%, hyperchromic effect with polycytidine monophosphate>65%, the output of injection/kg> 0.47 million pieces(2mg2ml). introduction it can be used in the therapy of herpes simplex keratitis, herpes zoster, herpeticgingivostomatitis, it also can offer good effects to hepatitis b, epidemic hemorrhagic fever, virus flu and flat wart. moreover, it can cure nasopharyngeal cancer and gynecologic cancers. packing250g/bottle 500g/bottle polyinosinic acid (poly i) cas no. 30918-54-8 itemsrequirementsresultsdescription white powder or off- white powder ,easily soluble in water ,practically insoluble in ethanol,ether .conformity absorption ratioa250 / a260 = 1.59~1.65a280 / a260 = 0.27~0.31λmax=248nma250 / a260 = 1.61a280 / a260 = 0.30λmax=248.5nmph6.0~8.08.0transmittance of solutionnot less than 98.0% 99.4%clarity of solutionconformityconformityloss on dryingnot more than8.0%6.8%sendiment coefficientnot less than 4sconformitycontents (on drysis)not less than90.0% 91.6%